A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2

by Soo-Youl Kim, Jeffrey W. Keillor
Published 2020-04-01

Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.

by Gozde Colak, Jeffrey W Keillor, Gail V W Johnson
Published 2011-01-01

Design of a glutamine substrate tag enabling protein labelling mediated by Bacillus subtilis transglutaminase.

by Samuel K Oteng-Pabi, Christopher M Clouthier, Jeffrey W Keillor
Published 2018-01-01

Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells.

by Nicholas S Caron, Lise N Munsie, Jeffrey W Keillor, Ray Truant
Published 2012-01-01

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Tran...

by Károly Jambrovics, Iván P. Uray, Jeffrey W. Keillor, László Fésüs, Zoltán Balajthy
Published 2020-03-01

Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation

by Kelvin K. Tsao, Ann C. Lee, Karl É. Racine, Jeffrey W. Keillor
Published 2020-02-01

Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.

by Hadil F Al-Jallad, Vamsee D Myneni, Sarah A Piercy-Kotb, Nicolas Chabot, Amina Mulani, Jeffrey W Keillor, Mari T Kaartinen
Published 2011-01-01